Xolair is a brand-name prescription medication and is a biologic. Its active ingredient is called omalizumab. Generic versions of biologic medications are called biosimilars. Due to complex ...
Xolair is a brand-name prescription medication known as a biologic. Its active ingredient is omalizumab. Generic versions of biologic drugs are called biosimilars. Due to complex manufacturing ...
Budget impact analysis finds omalizumab biosimilars in Europe could cut payer costs by €641M in 5 years, expanding access and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results